• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Re: Daniel D. Shapiro, Jose A. Karam, Logan Zemp, et al. Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Therapy Is Safe and Facilitates Treatment-free Intervals. Eur Urol Open Sci 2023;50:43-6.

作者信息

Ghoreifi Alireza, Djaladat Hooman

机构信息

Catherine and Joseph Aresty Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.

Catherine and Joseph Aresty Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.

出版信息

Eur Urol. 2023 Aug;84(2):e53-e54. doi: 10.1016/j.eururo.2023.03.042. Epub 2023 May 5.

DOI:10.1016/j.eururo.2023.03.042
PMID:37149463
Abstract
摘要

相似文献

1
Re: Daniel D. Shapiro, Jose A. Karam, Logan Zemp, et al. Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Therapy Is Safe and Facilitates Treatment-free Intervals. Eur Urol Open Sci 2023;50:43-6.回复：丹尼尔·D·夏皮罗、何塞·A·卡拉姆、洛根·曾普等。免疫检查点抑制剂治疗后减瘤性肾切除术安全且有助于延长无治疗间期。《欧洲泌尿外科开放科学》2023年；50卷：43 - 6页
Eur Urol. 2023 Aug;84(2):e53-e54. doi: 10.1016/j.eururo.2023.03.042. Epub 2023 May 5.
2
Reply to Alireza Ghoreifi and Hooman Djaladat's Letter to the Editor re: Daniel D. Shapiro, Jose A. Karam, Logan Zemp, et al. Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Therapy Is Safe and Facilitates Treatment-free Intervals. Eur Urol Open Sci 2023;50:43-6.对阿里雷扎·戈雷菲和胡曼·贾拉达特致编辑的信的回复：关于丹尼尔·D·夏皮罗、何塞·A·卡拉姆、洛根·曾普等人的《免疫检查点抑制剂治疗后减瘤性肾切除术安全且有助于无治疗间期》。《欧洲泌尿外科开放科学》2023年；50:43 - 6。
Eur Urol. 2023 Aug;84(2):e55-e56. doi: 10.1016/j.eururo.2023.04.023. Epub 2023 May 5.
3
Reply to Daniel D. Shapiro, Jose A. Karam, Viraj A. Master, et al.'s Letter to the Editor re: Wesley Yip, Alireza Ghoreifi, Thomas Gerald, et al. Perioperative Complications and Oncologic Outcomes of Nephrectomy Following Immune Checkpoint Inhibitor Therapy: A Multicenter Collaborative Study. Eur Urol Oncol. Eur Urol. Onc. 2023;604-610.对丹尼尔·D·夏皮罗、何塞·A·卡拉姆、维拉杰·A·马斯特等人致编辑信的回复，信的主题为：韦斯利·叶、阿里雷扎·戈雷菲、托马斯·杰拉尔德等人。免疫检查点抑制剂治疗后肾切除术的围手术期并发症和肿瘤学结局：一项多中心合作研究。《欧洲泌尿外科肿瘤学》。《欧洲泌尿外科》。肿瘤学。2023年；604 - 610页。
Eur Urol Oncol. 2023 Dec;6(6):637. doi: 10.1016/j.euo.2023.05.010. Epub 2023 Jun 12.
4
Re: Ziad Bakouny, Talal El Zarif, Shaan Dudani, et al. Upfront Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors or Targeted Therapy: An Observational Study from the International Metastatic Renal Cell Carcinoma Database Consortium. Eur Urol 2023;83:145-51.回复：齐亚德·巴库尼、塔拉勒·埃尔·扎里夫、沙恩·杜达尼等人。免疫检查点抑制剂或靶向治疗的转移性肾细胞癌的 upfront 减瘤性肾切除术：来自国际转移性肾细胞癌数据库联盟的一项观察性研究。《欧洲泌尿外科杂志》2023 年；83 卷：145 - 151 页。
Eur Urol. 2023 Sep;84(3):e75. doi: 10.1016/j.eururo.2023.04.040. Epub 2023 Jun 1.
5
Re: Bimal Bhindi, Jeffrey Graham, J. Connor Wells, et al. Deferred Cytoreductive Nephrectomy in Patients with Newly Diagnosed Metastatic Renal Cell Carcinoma. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.04.038: Cytoreductive Nephrectomy: To Whom and When?回复：比马尔·宾迪、杰弗里·格雷厄姆、J·康纳·韦尔斯等人。初诊转移性肾细胞癌患者的延期减瘤性肾切除术。《欧洲泌尿外科杂志》。即将发表。https://doi.org/10.1016/j.eururo.2020.04.038：减瘤性肾切除术：适用于谁以及何时进行？
Eur Urol Oncol. 2020 Aug;3(4):559-560. doi: 10.1016/j.euo.2020.05.011. Epub 2020 Jun 15.
6
Surgical Safety of Deferred Cytoreductive Nephrectomy Following Pretreatment with Immune Checkpoint Inhibitor-based Dual Combination Therapy.基于免疫检查点抑制剂的双联联合疗法预处理后延期减瘤性肾切除术的手术安全性
Eur Urol Oncol. 2022 Jun;5(3):373-374. doi: 10.1016/j.euo.2021.11.004. Epub 2021 Dec 20.
7
Re: Upfront Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors or Targeted Therapy: An Observational Study from the International Metastatic Renal Cell Carcinoma Database Consortium.回复：免疫检查点抑制剂或靶向治疗的转移性肾细胞癌的初始细胞减灭性肾切除术：来自国际转移性肾细胞癌数据库联盟的一项观察性研究
Eur Urol. 2023 Aug;84(2):244-245. doi: 10.1016/j.eururo.2023.03.034. Epub 2023 Apr 21.
8
A Swinging Pendulum: Bringing Back Cytoreductive Nephrectomy in the Era of Immune Checkpoint Inhibition.一个摆动的钟摆：在免疫检查点抑制时代恢复减瘤性肾切除术
Eur Urol Oncol. 2022 Oct;5(5):585-586. doi: 10.1016/j.euo.2022.07.009. Epub 2022 Aug 12.
9
Re: Bimal Bhindi, E. Jason Abel, Laurence Albiges, et al. Systematic Review of the Role of Cytoreductive Nephrectomy in the Targeted Therapy Era and Beyond: An Individualized Approach to Metastatic Renal Cell Carcinoma. Eur Urol 2019;75:111-28: Cytoreductive Nephrectomy in the Targeted Therapy Era: This is Not the End.回复：比马尔·宾迪、E. 贾森·阿贝尔、劳伦斯·阿尔比热斯等。减瘤性肾切除术在靶向治疗时代及以后作用的系统评价：转移性肾细胞癌的个体化治疗方法。《欧洲泌尿外科杂志》2019年；75卷：111 - 128页：靶向治疗时代的减瘤性肾切除术：这并非终点。
Eur Urol Oncol. 2019 Sep;2(5):603-604. doi: 10.1016/j.euo.2019.01.005. Epub 2019 Jan 31.
10
Radical Nephrectomy After Immune Checkpoint Inhibitors for Metastatic Renal Cell Carcinoma.免疫检查点抑制剂治疗转移性肾细胞癌后的根治性肾切除术。
Eur Urol Focus. 2023 Mar;9(2):275-277. doi: 10.1016/j.euf.2023.01.022. Epub 2023 Feb 10.